ask="4.99"
ask_size="1100"
average_daily_volume="750064"
bid="4.50"
bid_size="1000"
book_value="5.03"
change="N/A"
change_from_200_day_moving_average="1.74"
change_from_50_day_moving_average="1.41"
change_from_52_week_high="-13.58"
change_From_52_week_low="3.17"
change_in_percent="N/A"
close="4.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.22"
ebitda="-104.38M"
eps_estimate_current_year="-9.70"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-4.55"
ex_dividend_date="N/A"
float_shares="9594000"
high="N/A"
high_52_weeks="18.40"
last_trade_date="2/13/2017"
last_trade_price="4.82"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="1.65"
market_capitalization="70.30M"
moving_average_200_day="3.08"
moving_average_50_day="3.41"
name="Orexigen Therapeutics
Inc."
notes="N/A"
one_year_target_price="11.67"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.01"
percent_change_from_200_day_moving_average="+56.36%"
percent_change_from_50_day_moving_average="+41.27%"
percent_change_from_52_week_high="-73.80%"
percent_change_from_52_week_low="+192.12%"
previous_close="4.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.96"
price_per_sales="2.84"
revenue="24.76M"
shares_outstanding="14586000"
short_ratio="2.03"
stock_exchange="NMS"
symbol="OREX"
volume="0"
weeks_range_52="1.65 - 18.40"
